State Street’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

State Street’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-443,872	Closed	-$44.5M	–	3848
2015 Q1	$44.5M	Buy	443,872 +321,611	+263%	+$21.4M	﹤0.01%	1303
2014 Q4	$6.41M	Sell	122,261 -31,278	-20%	-$918K	﹤0.01%	2441
2014 Q3	$3.94M	Buy	153,539 +24,628	+19%	+$524K	﹤0.01%	2664
2014 Q2	$2.87M	Buy	128,911 +51,712	+67%	+$1.13M	﹤0.01%	2886
2014 Q1	$2.37M	Buy	+77,199	New	+$2.07M	﹤0.01%	2984

State Street's ASPX Position: Q2 2015 in Review

State Street sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 443,872 shares — an estimated $44.5M sold.

State Street first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $44.5M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

State Street reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
State Street sold 443,872 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $44.5M.
State Street first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
State Street's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $44.5M in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on State Street's 13F filing for Q2 2015, filed 13 Aug 2015.